FundX Investment Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-15,000
Closed -$385K 39
2020
Q1
$385K Buy
+15,000
New +$357K 0.14% 28

Other funds holding BTAL

FundX Investment Group's BTAL Position: Q2 2020 in Review

FundX Investment Group sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2020, closing a stake of 15,000 shares — an estimated $385K sold.

FundX Investment Group first reported a position in BTAL in Q1 2020 and held it in 1 quarter. The position peaked at $385K in Q1 2020. 40 funds tracked by Wall St. Rank hold BTAL as of Q2 2020.

  • FundX Investment Group reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2020 after selling out during the quarter.
  • FundX Investment Group sold 15,000 AGF US Market Neutral Anti-Beta Fund shares in Q2 2020, an estimated $385K.
  • FundX Investment Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2020 and held it in 1 quarter.
  • FundX Investment Group's AGF US Market Neutral Anti-Beta Fund position peaked at $385K in Q1 2020.
  • 40 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2020.

Based on FundX Investment Group's 13F filing for Q2 2020, filed 11 Aug 2020.